Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
St. Jude Children's Research Hospital
University of Miami
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
AIDS Malignancy Consortium
University of Nebraska
University of Nebraska
Janssen Research & Development, LLC
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
City of Hope Medical Center
Roswell Park Cancer Institute
Weill Medical College of Cornell University
SWOG Cancer Research Network
Columbia University
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
CTI BioPharma
Fred Hutchinson Cancer Center
Celgene
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Seagen Inc.
St. Jude Children's Research Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Weill Medical College of Cornell University
Asan Medical Center
Stanford University
City of Hope Medical Center
Stanford University
Washington University School of Medicine
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Stanford University
Massachusetts General Hospital
University of Washington
University of Washington
Weill Medical College of Cornell University
Massachusetts General Hospital
M.D. Anderson Cancer Center
City of Hope Medical Center
New Mexico Cancer Research Alliance
SWOG Cancer Research Network
City of Hope Medical Center
Otsuka Pharmaceutical Development & Commercialization, Inc.